A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor ; volume:21 ; number:3 ; day:29 ; month:7 ; year:2021 ; pages:273-283 ; date:9.2021
Drugs in R & D ; 21, Heft 3 (29.7.2021), 273-283, 9.2021
- Urheber
-
Rajpoot, Sajjan
Ohishi, Tomokazu
Kumar, Ashutosh
Pan, Qiuwei
Banerjee, Sreeparna
Zhang, Kam Y. J.
Baig, Mirza S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-021-00357-0
- URN
-
urn:nbn:de:101:1-2021110219383557132121
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rajpoot, Sajjan
- Ohishi, Tomokazu
- Kumar, Ashutosh
- Pan, Qiuwei
- Banerjee, Sreeparna
- Zhang, Kam Y. J.
- Baig, Mirza S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model
SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication
Cryo-EM structures of SARS-CoV-2 BA.2-derived subvariants spike in complex with ACE2 receptor
ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors
Characterization of biotinylated human ACE2 and SARS-CoV-2 Omicron BA.4/5 spike protein reference materials
ACE2: the molecular doorway to SARS-CoV-2
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model
SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication
Cryo-EM structures of SARS-CoV-2 BA.2-derived subvariants spike in complex with ACE2 receptor
ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors
Characterization of biotinylated human ACE2 and SARS-CoV-2 Omicron BA.4/5 spike protein reference materials
ACE2: the molecular doorway to SARS-CoV-2
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model
SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication
Cryo-EM structures of SARS-CoV-2 BA.2-derived subvariants spike in complex with ACE2 receptor
ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors
Characterization of biotinylated human ACE2 and SARS-CoV-2 Omicron BA.4/5 spike protein reference materials